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Jaks, STATs, Cytokine Signal Review
Transduction, and Immunoregulation:
Are We There Yet?
John J. O'Shea al., 1991; Kopf et al., 1993). IL-7 is important for the
development and/or survival of T cells and B cells; miceLymphocyte Cell Biology Section
Arthritis and Rheumatism Branch lacking this cytokine or its receptor are profoundly
lymphopenic (von Freeden-Jeffry et al., 1995; PeschonNational Institute of Arthritis and
Musculoskeletal and Skin Diseases et al., 1994). IL-2, however, has both positive and nega-
tive effects on the immune response. A major abnormal-National Institutes of Health
Bethesda, Maryland 20892-1820 ity seen in IL-2±, IL-2 receptor a chain (IL-2Ra)±, and IL-
2Rb±deficient mice is the development of autoimmune
disease and lymphoid expansion (Kundig et al., 1993;
Sadlack et al., 1993; Willerford et al., 1995; Suzuki et al.,The impatient refrain ªAre we there yet?,º echoing from
1995). IL-10 is another cytokine that appears to hold thethe back seat, is a familiar one to any parent. The
immune response in check; IL-10 knockout mice alsoquestion, though, is a valid one for the impatient immu-
have severe immunologic disease (Kuhn et al., 1993).nologist struggling to understand the regulation of the
Thus, it is clear that cytokines play a central role inimmune response. That is, abundant data exist to sub-
immunoregulation. But how does this occur? What doesstantiate the role of various cytokines in immunoreg-
this mean on a molecular level? How do specific cyto-ulation (Paul and Seder, 1994; Abbas et al., 1996). Con-
kines regulate the expression of specific genes?comitantly, striking advances have been made recently
in understanding cytokine signaling. But do these ad-
Cytokine Signal Transduction and Jaksvances provide a satisfactory molecular explanation for
Unlike growth factor receptors and the transformingcytokine actions and the processes involved in regulat-
growth factor b/activin family of receptors, which haveing the immune response?
intrinsic enzymatic activity (as tyrosine and serine/threo-The discoveries of Janus kinases (Jaks) (Figures 1 and
nine kinases, respectively), cytokine receptors lack in-2) and signal transducers and activators of transcription
trinsic catalytic activity. Rather, they are associated with(STATs) (Figure 3) have explained a great deal about
a structurally unique class of kinases, the Jaks: Jak1,signaling by cytokine receptors. One appeal of the Jak/
Jak2, Jak3, and Tyk2 (Figures 1 and 2) (reviewed by IhleSTAT pathway is that the trail from membrane to gene
et al., 1995; Johnston et al., 1996). The function of Jaksregulation is remarkably direct. In addition, although the
was uncovered by the generation of cell lines resistantJaks do not provide an explanation for the specificity
to the effects of interferons, whose defects could beof cytokine signaling, cytokine receptors and STATs do.
complemented by expression of different Jaks (Velaz-This review focuses on the relationship of cytokine sig-
quez et al., 1992; Muller et al., 1993a; Silvennoinen etnaling to immunoregulation. In particular, humans and
al., 1993; Watling et al., 1993). Subsequently, it wasmice that lack specific Jaks and STATs are discussed
found that various Jaks are activated by all the a-helical(Table 1), because these examples provide clear illustra-
cytokines (summarized by Ihle, 1995; Johnston et al.,tions of the importance of the Jak/STAT pathway in
controlling the immune response.
Cytokines, Cytokine Receptors,
and Immunoregulation
The term ªcytokineº encompasses an array of diverse
soluble factors. One subset of cytokines includes more
than 30 factors and comprises the a-helical cytokines.
These cytokines bind to a class of receptors known
as type I cytokine receptors and include interleukins,
colony-stimulating factors, and hormones (Bazan, 1990).
Closely related are the receptors for the interferons (type
II cytokine receptors). This superfamily can be further
divided into subgroups based on the use of shared sub-
units (Taga and Kishimoto, 1995; Leonard, 1996). For
instance, the common g chain (gc) is a subunit of the
interleukin-2 (IL-2), IL-4, IL-7, IL-9, and IL-15 receptors.
This feature of cytokine receptors provides one molecu- Figure 1. Structure of Jaks
lar explanation for the redundant nature of cytokines. Among metazoan tyrosine kinases, the Jaks are structurally unique
in that they contain a C-terminal catalytic domain and an adjacentThe importance of cytokines in immunoregulation is
pseudokinase domain. These segments constitute the first two Jaknow well documented. IL-12 and interferon-g (IFNg) are
homology (JH) domains, JH1 and JH2, respectively. Other con-important in promoting cell-mediated responses, and
served segments within the Jaks have been noted and are identifiedIL-12 knockout mice have impaired T helper cell 1 (Th1)
as JH domains, although their functions have not been ascertained.
responses (Magram et al., 1996). Conversely, IL-4 and However, the N terminus has been found to be important in the
IL-5 are key mediators of allergic responses, and IL-4 binding of the Jaks to cytokine receptors. The chromosomal local-
ization of the Jaks is also shown. See Ihle et al., 1995.knockout mice have impaired Th2 responses (Kuhn et
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1996). Jak1 and Jak2 are activated by a broad range of (Macchi et al., 1995; Russell et al., 1995). Jak3 knockout
mice have also been generated, and they too are immu-cytokines, and Tyk2 is activated by cytokines that utilize
gp130 (IL-6 and other cytokines), IL-10, IL-12, and IL- nodeficient (Thomis et al., 1995; Nosaka et al., 1995;
Park et al., 1995). Curiously, the phenotype of Jak3-13 in addition to IFNa/b. In contrast, Jak3 specifically
associates only with gc (Russell et al., 1994; Miyazaki et deficiency differs in humans and mice. Whereas Jak3-
and gc- deficient humans lack T cells but contain B cellsal., 1994; Boussiotis et al., 1994) and is only activated
by cytokines that bind to gc-containing receptors. The (albeit dysfunctional B cells), Jak3- and gc-deficient mice
(Cao et al., 1995; DiSanto et al., 1995) have a few func-use of Jaks by different cytokine receptors is illustrated
in Figure 4. tionally impaired T cells but lack B cells. Precisely why
Jak3- and gc-deficiency blocks normal lymphocyte de-Thus, Jaks fit the bill as key mediators of signaling by
cytokine receptors in that they physically associate with velopment is not completely understood, but may relate
to absent IL-7 signaling. But why the difference betweencytokine receptor subunits and are essential for cytokine
signaling. mice and humans? Perhaps there exist alternative re-
ceptors or cytokines that rescue B cell development in
a species-specific manner.Jaks and Development
What is the significance to the organism of the absence T cells that are produced in gc- and Jak3-deficient
mice have an abnormal phenotype. They appear acti-of a given Jak? Thus far we only have information on one
mammalian Jak, Jak3. Mutation of gc, which specifically vated in their expression of high levels of CD44 and low
levels of CD62L (Thomis and Berg, 1997; Nakajima etassociates with Jak3, is the molecular basis of X-linked
severe combined immunodeficiency (X-SCID) (Table 1) al., 1997; Saijo et al., 1997). In the case of Jak3-deficient
mice, impaired negative selection in the thymus has(Noguchi et al., 1993; Leonard, 1996). The function of gc
as a component of many cytokine receptors helps to been reported (Saijo et al., 1997), suggesting that their
abnormal T cell phenotype may reflect activation ofexplain the severity of this immunodeficiency. The inti-
mate association of Jak3 and gc suggested that muta- autoreactive clones in the periphery. The phenotype of
Jak3 deficiency may also be analogous to the lymphoidtions of Jak3 itself might also cause SCID (Russell et
al., 1994), and patients with autosomal recessive SCID expansion seen IL-2Ra nullizygous mice. In addition,
the phenotype of Jak3 deficiency may be unrelated todue to Jak3 mutations were subsequently identified
gc mediated signaling and may reflect a requirement
for Jak3 functioning in other signaling pathways. For
example, Jak2 has recently been shown to be involved
CD40 signaling (Hanissian and Geha, 1997).
Despite the documentedessential role of Jaks in cyto-
kine signaling, only Jak3 knockout mice have been gen-
erated. However, the zebrafish Jak1 was recently cloned
and was shown to play an important role in early verte-
brate development (Conway et al., 1997). It was found
to be maternally encoded, stored in unfertilized eggs,
and expressed throughout the midblastula stage. There-
after it rapidly disappears but is reexpressed later. The
mRNA is evenly distributed among the cells of blastula-
stage embryos, and injection of RNA encoding domi-
nant-negative Jak1 kinases inhibited cell migration; re-
duced expression of goosecoid, a transcription factor
that is expressed in dorsal mesoderm; and interfered
Figure 2. A Model for the Role of Jaks and STATs in Cytokine Signal with anterior structure formation.
Transduction
Another system that vividly demonstrates the impor-
Cytokine binding to receptor subunits induces homo- or heterodi- tance of the Jaks in development is the analysis of the
merization resulting in the apposition of Jaks that are bound to the
function of the Drosophila Jak (Hou and Perrimon, 1997).receptor chains. The N terminus of the Jaks is probably important
Termed Hopscotch (HOP), it is structurally remarkablyfor receptor association. Bringing the Jaks into proximity allows the
similar to the mammalian Jaks. It is about 26% identicalJaks to become activated, likely through transphosphorylation. Like
other tyrosine kinases, phosphorylation of tyrosine residues within and 50% similar to Jak2; identity within the catalytic
the activation loop of the kinase domain is probably an essential part (JH1) domain is even greater. Mutation of the hop gene
of this activation. The activated Jaks phosphorylate the cytokine results in marked developmental abnormalities through
receptor subunits providing docking sites for proteins with SH2
both maternal and zygotic effects. Absence of maternaldomains. The STAT family of transcription factors is one important
and zygotic hop results in severe segmentation defects,class. STATs boundto cytokinereceptors are themselves phosphor-
whereas embryos that have one copy of a paternallyylated on a C-terminal tyrosine residue. This site in turn is recognized
by the SH2 domain of another STAT molecule allowing dimerization derived wild-type allele have less severe defects. Prog-
to occur. Homo- and hetero-dimerized STATs translocate to the eny from females homozygous for the weak hop allele,
nucleus and bind DNA, thereby regulating gene expression. Other hopmsv1, have subtle segmentation defects. In embryos
mechanisms may be involved in STAT±receptor interactions and
with mutation of hop, stripe-specific defects in the ex-alternative means for STAT activation may exist. Aside from their
pression patterns of pair-rule genes (even-skipped, runt,role as transcription factors, STATs may also function as adapter
and fushi tarazu) and segment-polarity genes (engrailedmolecules for coupling receptors to other signaling pathways. That
is, STAT3 has been reported to bind phosphatidylinositol 3-kinase. and wingless) occur (Binari and Perrimon, 1994). These
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Table 1. Summary of the Cytokines That Activate the Jaks and STATs and the Phenotypes Associated with Their Deficiencies




JAK2 Many cytokines ND
JAK3 gc cytokines Combined immunodeficiency#
TYK2 IFNa/b, IL-10, IL-12, others ND
STAT1 IFNs, other cytokines and growth factors Viral susceptibility impaired IFN signaling
STAT2 IFNa/b ND
STAT3 Many cytokines and other stimuli Embryonically lethal
STAT4 IL-12, IFNa/b (human) Impaired IL-12 signaling and Th1 development
STAT5A Many hormones, interleukins, CSFs, other Impaired lactation and mammary development
STAT5B Many hormones, interleukins, CSFs, other ND
STAT6 IL-4 Impaired IL-4 signaling and Th2 differentiation
The Jak and STAT knockout mice that have been produced are described in the text.
a A mammalian Jak1 knockout has not been reported, but in zebrafish, maternally derived Jak1 appears to be essential for embryogenesis
(Conway et al., 1997).
b Cases of Jak3 deficiency in humans have been identified, but no human cases have been identified that lack other Jaks or STATs.
ND, no data.
findings raise a number of important questions. For in- activity regulated? Phosphorylation of tyrosine residues
that reside in the activation loop of tyrosine kinasesstance, how many Jaks do Drosophila have, or do they
have just one? Are there separate Jak1, Jak2 and Tyk2 typically positively regulate catalytic activity. For Tyk2
and Jak2, mutation of these tyrosines are known toorthologs? If so, are they regulated by cytokines? In-
deed, if flies have cytokines and Jaks, what about other inhibit Jak activity (Gauzzi et al., 1996; Feng et al., 1997).
However, there are many other conserved tyrosine resi-organisms, such as Caenorhabditis elegans? Interest-
ingly, a C. elegans Jak has been identified in the se- dues within the Jaks whose functions are not yet under-
stood. Variant Jak isoforms have also been identified.quencing of the C. elegans genome. Clearly this is a
very old pathway for cellular differentiation. In the case of Jak3, three splice variants that contain
identical N-terminal regions but that diverge at the C
termini have been isolated. One form appears to beJaks and Transformation
In several circumstances, mutations of Jaks provide catalytically inactive, but its precise role in signaling is
not understood (Lai et al., 1995).clear evidence that Jaks are essential for normal growth
and development. But what about transformation? Can An intriguing aspect of the structure of Jaks is the
presence of a pseudokinase domain, a feature that isdysregulation of Jaks lead to cancer? Of great interest
in this regard is that activating mutations of hop also conserved among insect, fish, and mammalian Jaks but
whose function has not been clearly defined. Mutationshave striking consequences. These mutations, known
as Tum-l (tumorous lethal) mutations, result in leukemia in the JH2 domain clearly alter Jak function (Luo et al.,
1997; Velazquez et al., 1995), and the presence of thisin flies (Hanratty and Dearolf, 1993; Harrison et al., 1995;
Luo et al., 1995; Luo et al., 1997). Thus far, however, no catalytically inactive domain may be important in regu-
lating enzymatic activity. In addition, it has recently beencircumstances have been identified in which a human
cancer is the result of mutation or translocation of a reported that the JH2 domain binds STATs (Fujitani et
al., 1997). Thus, it is unlikely that this segment is simplyJak. Nonetheless, there are a number of circumstances
in which constitutive activation of Jaks is associated vestigial. Clearly, structural studies of the Jaks are ea-
gerly anticipated.with malignant transformation. This was first demon-
strated in human T cell leukemia virus I±transformed T Our ignorance of the details of Jak structure and func-
tion extends to the remaining conserved segments ofcells (Migone et al., 1995). Constitutive Jak activation
has also been found in other settings, including Sezary's the Jaks. Jaks have a domain that is reminiscent of a
Src homology 2 (SH2) domain, although the ability ofsyndrome (Zhang et al., 1996), v-abl±transformed cells
(Danial et al., 1995), and acute lymphoblastic leukemia this domain to bind phosphorylated tyrosine residues
has not been demonstrated. Mutation of the arginine(Meydan et al., 1996). Finally, transformation may also
result from mutations of cytokine receptor subunits. Two corresponding to the conserved residue in other SH2
domains did not have an identifiable consequence (Kohl-examples are mutationsof the thrombopoietin receptors
(v-mpl) (Souyri et al., 1990) and erythropoietin receptors huber et al., 1997).
In a number of receptor systems it has been demon-(Longmore and Lodish, 1991), both of which lead to
constitutive dimerization of the receptors and, hence, strated that Jaks are constitutively associated with cyto-
kine receptor subunits. The membrane proximal domainconstitutive Jak activation.
of the cytokine receptors appears to be required for
association with Jaks, and the proline-rich box 1 motifOther Unanswered Questions Pertaining to Jaks
A number important points regarding the Jaks remain appears to be particularly important (Figure 2) (Yan et
al., 1996b). The component of the Jaks that binds to theincompletely understood. For instance, how does Jak
structure related to its functions and how is Jak catalytic cytokine receptor is less clear. However, several studies
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associated with SHP-2, but is it responsible for Jak de-
phosphorylation (Yin et al., 1997)? While this has not
been determined, SHP-2 generally functions as a posi-
tive regulator of signaling and does not attenuate it (Ali
et al., 1996).
Although known substrates for Jaks include STATs
and receptor chains, there undoubtedly are other Jak
substrates as well. For instance, the signal-transducing
adapter molecule STAM hasbeen shown to be important
in cytokine regulation of the c-myc gene and cell growth
(Takeshita et al., 1997). Conversely, despite the impor-
tance of Jak3 for IL-2 signaling, some aspects of IL-2
signaling may be independent of Jak3. For example,
IL-2 induction of Bcl-2 and Bag-1 and phosphorylation
of SHP-2 were not inhibited by overexpression of a dom-
inant negative allele of Jak3, even though IL-2±depen-Figure 3. Structure of STATs
dent regulation of c-fos and c-myc was abrogated and
The signal transducer and activator of transcription (STAT) family
cellular proliferation was inhibited (Kawahara et al.,of transcription factors are notable structurally by the presence of
1995; Adachi et al., 1996, 1997). Indentifying other Jaka central DNA binding domain, an SH3-like domain, and an SH2
domain. C-terminal to the SH2 domain there is a conserved tyrosine substrates and dissecting Jak-dependent and Jak-inde-
residue that is phosphorylated upon cytokine stimulation and that pendent signaling pathways will be important.
is essential for STAT dimerization. The STAT SH2 domain serves Thus, much work remains to be done to elucidate the
both to bind to the phosphorylated cytokine receptor and to effect
structure and function and the regulation of the Jaks.STAT dimerization. For some STATs, phosphorylation of a C-termi-
Nevertheless, it is already clear that activation of specificnal serine residue (shown in parentheses) may also important for
Jaks cannot explain the specificity of cytokine signaling.transcriptional activation. The extreme C terminus is divergent and
influences transcriptional activation. The N terminus of the STATs, First, multiple cytokines activate the same Jaks (e.g.,
which is also conserved, is important for protein-protein interac- IL-2 and IL-4). Second, experimentally recruiting differ-
tions. Functions ascribed to this region include association with ent Jaks to a given cytokine receptor does not affect
other STATs and receptor binding. The chromosomal localization
the specificity of thesignal. So, if the Jaks do not provideof the STAT molecules is also shown. The localization of the some
signal specificity, what does? The answer is that signalSTATs (asterisks) is based on mapping of the mouse genes. See
specificity resides in the STAT family of tyrosine-phos-Ihle et al., 1995.
phorylated transcription factors.
STATs: Their Critical Role in Transmittinghave provided evidence that the Jak N terminus is re-
sponsible for this binding (Frank et al., 1994; Zhao et Cytokine Signals
STATs were firstdiscovered inprotein complexes boundal., 1995; Kohlhuber et al., 1997; Chen et al., 1997).
How is Jak signaling terminated? The SH2-containing to the promoters of interferon-inducible genes (reviewed
by Darnell et al., 1994; Schindler and Darnell, 1995; Ihle,tyrosine phosphatase, SHP-1, can associate with cyto-
kine receptors (e.g., the erythropoietin receptor) and 1996). Seven STATs have now been cloned: STAT1,
STAT2, STAT3, STAT4, STAT5A, STAT5B, and STAT6regulate Jak2 phosphorylation (Klingmuller et al., 1995).
Whether other cytokine receptors and Jaks are regu- (Figure 3). These transcription factors bind a nucleotide
consensus motif of TTNCNNNAA, termed a GAS (IFNg±lated similarly has not been documented. Jaks are also
Figure 4. Mechanisms by Which Specificity
Is Achieved in Cytokine Signaling
The membrane proximal region of cytokine
receptors is responsible for the binding of
distinct Jaks likely through their N termini.
However, this does not explain how different
STATs are activated by different cytokines.
Rather, specific residues in the receptor that
surround phosphorylated tyrosines are rec-
ognized by STAT SH2 domains, thus provid-
ing a mechanism for the recruitment of differ-
ent STATs to different receptors. Although a
consensus binding sequence can be defined
for STATs, the different STATs bind DNA ele-
ments with some selectivity, providing an
additional layer of specificity. The optimal




activated site) element even though this sequence binds are activated by an extensive list of cytokines, including
prolactin, growth hormone, erythropoietin, thrombo-STATs induced by a variety of cytokines (Figure 3). The
interferon response element (ISRE) is different in its poietin, granulocyte±macrophage colony-stimulating
factor, IL-2, and others. Even IFNg has been shown tocomposition, in that it is a nonpalindromic motif,
TTTCNNTTTC, that binds a complex of proteins (ISGF3): activate STAT5 (Meinke et al., 1996). Surprisingly, the
defects in STAT5A knockout mice are also remarkablySTAT1, STAT2, and a non-STAT protein, p48.
It was first shown that IFNa/b activates STAT1 and discrete (Liu et al., 1997). STAT5A knockout mice de-
velop normally and are indistinguishable from normalSTAT2 whereas IFNg activates only STAT1 (Schindler
et al., 1992, Fu, 1992; Shuai et al., 1992; Silvennoinen mice in terms of size, weight, and fertility. However,
mammary lobuloalveolar outgrowth during pregancy iset al., 1993; Shuai et al, 1993). Later it was shown that
some STATs, such as STAT3 and STAT5, are activated absent, and females fail to lactate after parturution be-
cause of failure of mammary gland differentiation. Al-by a variety of cytokines, whereas others seem to have
more limited function. For instance, STAT6 is acti- though STAT5B has 96% similarity with STAT5A and is
expressed coordinately during mammary gland devel-vated primarily by IL-4 (Hou et al., 1994) (Figure4); STAT4
in mice is activated only by IL-12, although in humans opment, STAT5B does not compensate for the absence
of STAT5A. Thus, STAT5A is an essential mediator ofit is also activated by IFNa/b (Bacon et al., 1995; Jacob-
son et al., 1995; Cho et al., 1996). The essential function mammopoietic and lactogenic signaling. A caveat, how-
ever, is that STAT5B phosphorylation is reduced inof STAT proteins in cytokine signaling was demon-
strated by the observation that IFNa/b signaling requires STAT5A gene±targeted mice, for reasons that are pres-
ently unclear. Surprisingly, no abnormality of lymphoidboth STAT1 and STAT2 whereas IFNg signaling requires
STAT1 (Muller et al., 1993; Leung et al., 1995). Notably, of hematopoietic development has been detected in
these mice.STAT1 can be activated by additional cytokines and
can even be activated by noncytokine stimuli, such as STAT3 is activated by many cytokines, including some
that activate STAT5A and STAT5B. In sharp contrastepidermal growth factor (Sadowski et al., 1993). Never-
theless, mice made deficient in STAT1 by gene targeting to STAT5A knockouts, no viable STAT3-deficient mice
have been obtained (Takeda et al., 1997). Analysis ofhave highly specificdefects (Durbinet al., 1996; Meraz et
al., 1996) (Table 1). STAT1-deficient mice lack interferon embryos at several gestation times revealed that STAT3-
deficient embryos showed degeneration betweensignaling and have marked susceptibility to viral infec-
tions. embryonic days 6.5 and 7.5, indicating that STAT3 is
essential for early embryonic development.Similarly, the phenotypes of STAT4 and STAT6
knockout mice are also quite discrete (Table 1). STAT4 Thus, with the exception of STAT3, which has essen-
tial functions in embryogenesis, other STATs have lim-knockoutmice are viable and fertile and have normal
hematopoiesis, but are unable to respond to IL-12: ited and specific functions even if they can be activated
by diverse stimuli.IL-12±induced mitogenesis, enhancement of natural
killer cytolytic function, and Th1 differentiation are mark- A Drosophila STAT (termed Marelle, DSTAT, and
STAT92E) has been cloned and underscores the impor-edly impaired. In addition, development of Th1 cells in
response to challenge with Listeria monocytogenes is tance of STATs in cellular differentation (Hou and Perri-
mon, 1997; Hou et al., 1996; Yan et al., 1996c, 1996d).abrogated in STAT4-deficient mice, which have a pro-
pensity for development of Th2 cells. Thus, STAT4 is Mutation of the stat92e gene exhibits a phenotype iden-
tical to that seen with mutations of hop. It is importantessential for mediating responses to IL-12 in lympho-
cytes and regulates T helper cell differentiation (Kaplan that reduction of stat92e gene activity suppresses the
phenotype associated with a gain-of-function hoptum-let al., 1996; Thierfelder et al., 1996).
STAT6 knockout mice have deranged IL-4 signaling mutation. Conversely, it also enhances the phenotype
associated with a weak hop mutation. HOP then acti-and cannot generate a Th2 response (Kaplan et al., 1996,
Shimoda et al., 1996; Takeda et al., 1996). In STAT6- vates STAT92E to regulate transcription. As with mam-
malian STATs, STAT92E is phosphorylated on tyrosine,deficient mice, IL-4±induced up-regulation of major his-
tocompatibility class II expression, CD23, and IL-4 re- and the phosphorylated protein binds specifically to a
STAT DNA consensus sequence. Furthermore, twoceptor is abrogated. IL-4±mediated proliferation of T
and B cells is also reduced. STAT6-deficient B cells do STAT-binding sites have been identified within the eve
stripe 3 enhancer region, and mutations in either sitenot produce immunoglobulin E (IgE) following immuniza-
tion in vivo, and STAT6-deficient T lymphocytes do not greatly decrease stripe 3 expression in transgenic flies.
Therefore, the invertebrate Jak/STAT system is clearlydifferentiate into Th2 cells in response to either IL-4 or
IL-13. The production of Th2 cytokines from T cells, as involved in Drosophila early development and is remark-
ably similar to that of mammals. Several questions arise:well as IgE and IgG1 responses, after nematode infec-
tion are also profoundly reduced. Thus, STAT6 is essen- How many STATs do insects have? Like vertebrates, do
invertebrates have specialized STATs that serve distincttial for mediating lymphocyte responses to IL-4. In con-
trast, leptin, a cytokine that regulates obesity, also has functions, or is there a single STAT? If insectsand worms
have Jaks and STATs, do they also have cytokines andbeen reported to activate STAT6 (Ghilardi et al., 1996).
However, STAT6-deficient mice are not obese, sug- cytokine receptors? How many different ones do they
have, and how do they regulate differentiation? How didgesting that STAT6 is not an irreplaceable component
in leptin signaling. the vertebrate immune system pirate this pathway for
its own regulation?In contrast to STAT4 and STAT6, which are activated
by a limited number of cytokines, STAT5A and STAT5B Remarkably, a STAT protein, termed Dd-STAT, has
Immunity
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recently been identified in Dictostelium (Kawata et al., site that recruits a specific STAT is well supported by
existing data (Figure 3) (Greenlund et al., 1994; Hou et1997). This protein was identified as a transcription fac-
al., 1994; Heim et al., 1995; Stahl et al., 1995; Yan et al.,tor that bound to the promoter of the ecmA gene, which
1996a). For example, IL-4 stimulates phosphorylation ofis involved in prestalk cell differentiation. It is homolo-
STAT6, which preferentially binds the sequence ASS-gous to metazoan STATs in the N terminus and DNA-
GEEGY-PO4-KPFQDLI, found within the IL-4 receptor abinding domain. Moreover, it has an SH2 domain and
chain (Schindler et al., 1995) (Figure 4). Similarly, IFNgis regulated by tyrosine phosphorylation. The element
activates STAT1, which selectively binds peptidein the ecmA gene has some similarity to an ISRE, and
TSFGY-PO4-DKPH, within the IFNg receptor (GreenlundDd-STAT can bind a typical mammalian ISRE. It is nota-
et al., 1995) but cannot bind the IL-4R±derived phospho-ble that this factor functions as both a transcriptional
peptide. STATs may also preassociate with cytokineactivator and a repressor. The identification of a Dicto-
receptors prior to phosphorylation via their N termini (Listelium STAT suggests that STATs probably arose early
et al., 1997). After binding to cytokine receptors, STATsin the evolution of multicellular organisms to mediate
are themselves phosphorylated. They are released fromintracellular communication. Although tyrosine kinases
the receptor and then dimerize and translocate to thecloned from Dictyostelium have a pseudokinase domain
nucleus, where they bind DNA. The dimerization ofupstream from the catalytic domain, they are not closely
STATs (homo- and heterodimerization) is also mediatedrelated to Jaks in other respects (Adler et al., 1996).
by phosphotyrosine±SH2 interactions (Shuai et al.,1994;Thus, STATs may have preceded Jaks evolutionarily.
Greenlund et al., 1995). That is, phosphorylation of theWhereas STATs have been clearly documented to
conserved C-terminal tyrosine residue (e.g., Y701 inhave essential roles in cellular differentiation, their role
STAT1) is essential, and mutation of this tyrosine phos-in cellular proliferation has been controversial. Mutated
phorylation site or the conserved arginine residue in theversions of receptors that can no longer bind STATs
STAT SH2 domain abrogatesDNA binding and transacti-have had variable effects on the ability of receptors to
vation. STATs also have an SH3-like domain, but its roletransmit a proliferative signal. Various STATs knockout
has not been determined. While STATs are recruited tomice, however, have blunted proliferative responses,
cytokine receptors and then phosphorylated, there isindicating that STATs do contribute to cellular prolifera-
also an everexpanding list of noncytokine stimuli thattion. Studies in Drosophila also indicate a role for STATs
also activate STATs. These receptors include growth
in both proliferation and transformation. In mammalian
factor receptors (receptor tyrosine kinases), G protein±
cells there are also circumstances in which constitutive
coupled receptors, and immune receptors. The mecha-
STAT activation is associated with transformation, al-
nisms by which this process occurs have not been well
though the mechanisms are not understood. In some
characterized.
cases of transformation, STAT activation is concomitant
Tyrosine phosphorylation of the STATs is probably
with constitutive Jak activation, but inother cases, STAT not the whole story. Several STATs (STAT1, STAT3, and
activation has been found without Jak activation. Some STAT4) have been shown to be serine phosphorylated
examples of this include transformation with v-src (Yu in response to cytokine stimulation (Boulton et al., 1995;
et al., 1995; Cao et al., 1996) and spleen focus-forming Wen et al., 1995; Zhang et al., 1995; Cho et al., 1996).
virus (Ohashi et al., 1996). Although STAT activation has Serine phosphorylation of STATs appears to be impor-
been found in Bcr/Abl transformation, analysis of Jak tant in transcriptional regulation, but whether it is essen-
activation has yielded conflicting results (Carlesso et al., tial for DNA binding is less clear. For STAT1, the site of
1996; Ilaria and Van Etten, 1996; Shuai et al., 1996). phosphorylation is S727. This residue lies within the
Constitutive STAT activation has been reported in hu- divergent C terminus, which appears to be important for
man leukemic cells by some groups (Gouilleux-Gruart transcriptional activation. This site is also a consensus
et al., 1996; Weber-Nordt et al., 1996) but not by others phosphorylation site for a proline-directed serine ki-
(Kanwar et al., 1996). nase, such as mitogen-activated protein kinase (MAPK).
Undoubtedly, STAT activation alone, however, does MAPK has been reported to be activated by interferon
not account for the proliferative response to cytokines; and to be associated with the interferon receptor (David
other pathways activated by cytokine receptors contrib- et al., 1995). MAPK is activated by other cytokines, but
ute to this response. This point is also discussed below. at this time the precise significance of STAT serine phos-
phorylation and the identity of the STAT serine kinase(s)
are controversial. Like STAT1, STAT5 has been shown
How STATs Accomplish Specific Signaling to be serine phosphorylated (Beadling et al., 1996), but
from Receptors to Genes STAT does not have a consensus MAPK phosphoryla-
Gene-targeted mice demonstrate that STATs have tion site in the C-terminal transcriptional activation
highly specific functions and are essential for immuno- domain.
regulation. But how are specific STATs activated by Specific cytokine receptors can recruit specific STATs,
specific cytokines? And how do STATs turn on specific but then what? Do STATs have any specificity in terms
genes? In addition to a central DNA-binding domain of the DNA sequences that they bind? The answer ap-
(Horvath et al., 1995; Schindler et al., 1995), STATs have pears to be yes (Schindler and Darnell, 1995; Seidel et
a single SH2 domain near their C termini (Figure 2). Like al., 1995; Ihle, 1996) (Figure 4). Although a core GAS
other SH2 domains, the STAT SH2 domain binds to sequence is identifiable, the precise spacing and com-
phosphorylated tyrosine residues, with adjacent resi- position of this motif appear to be distinct among differ-
dues influencing binding specificity. The model that Jaks ent STATs. For instance, the spacing between the palin-
dromic halfsites that generate an optimal STAT6 bindingphosphorylate receptor subunits to create a docking
Review
7
site (TTCCNNGGAA) is different from those for other Presently, our understanding of the STAT function is
limited. Although they are translocated to the nucleusSTATs. The delineation of these preferred sites is far
from complete, but it is becoming clear how a cytokine after activation, we understand neither the mechanism
underlying this translocation nor the reason that aresuch as IL-4 recruits a specific transcription factor that
can turn on specific genes. Conversely, the observation they retained in the cytoplasm prior to stimulation. In
addition, two mechanisms have been proposed for at-that some DNA sequences indiscriminately bind STATs
can explain the overlapping biological effects of some tenuating STAT activation: ubiquitination and dephos-
phorylation (Kim and Maniatis, 1996; Haspel et al., 1996).cytokines. The regulatory regions for genes such as
the IL-12Rb2 gene will be interesting to dissect, since However, the relative importance of these two mecha-
nisms and the identity of the STAT phosphatase are notexpression of this gene is positively regulated by IFNg
(in mice) and IFNa/b (in humans) but negatively regu- known. Also, multiple isoforms exist for several STATs,
some which function as inhibitors of the full-length formslated by IL-4 (Rogge et al., 1997; Szabo et al., 1997).
One of the most intriguing recent developments is the (Wang et al., 1996). What is the physiologic function of
these alternate STAT species, and how is the processfinding that the core GAS element is bound not only by
STATs but also by another transcription factor, Bcl-6. regulated? Last, the solution of the three-dimensional
structure of STAT proteins will be of great interest andEven more striking is that Bcl-6 knockout mice have
marked cardiac and pulmonary eosinophilic infiltrates. should improve our understanding of how these tran-
scription factors are regulated, how they bind DNA, andIn addition, they have exaggerated production of Th2
cytokines. Bcl-6 can repress IL-4±mediated transcrip- how they accomplish specific binding.
Now that a variety of knockout mice have been gener-tion of a STAT6-activated gene (Dent et al., 1997). One
explanation for the pathologic features of Bcl-6±defi- ated, these mice will provide excellent vehicles for re-
constitution studies with mutated version of Jaks andcient mice is unopposed IL-4 signaling due to the lack
of a repressor that binds STAT6 sites. Whether other STATs to elucidate structure±function relationships as
they relate to the organism. Moreover, given the specificSTAT repressor proteins exist is not known.
It is now well recognized that gene regulation is typi- phenotypes of STAT1, STAT4, and STAT6 knockout
mice, the search for human mutations of these genescally effected by the coordinated binding of multiple
transcription factors to the regulatory elemens. Within seems warranted. For STAT3, which has global effects
on development, it will be important to investigate thethe IFNg gene, STAT sites are arranged in multiple cop-
ies, and cooperative interactions among N-terminal do- loss of such a factor in a tissue- and organ-specific
manner to delineate its role in the adult animal.mains are required for optimal STAT binding (Xu et al.,
1996). Such cooperative binding interactions may en- A particularly important issue is how cytokines regu-
late cell growth and the contribution of Jaks and STATsable the STAT proteins to recognize variations of con-
sensus sites, promoting selectivity in transcriptional ac- to this process. Clearly, other pathways, including the
Ras/Raf/MAPK and phosphatidylinositol 3-kinase/AKTtivation. STATs have also been reported to associate
with other proteins, including the glucocorticoid recep- pathways are also turned on by cytokine receptors. How
do Jaks and STATs interact with this pathway? Recenttor and p300/CBP (Bhattacharya et al., 1996; Stocklin
et al., 1996). Understanding the regulation of genes by data show that STATs also serve as adapter molecules
for the coupling of cytokinereceptors with phosphatidyl-cytokines will require careful dissection of the promoter
binding sites of these genes and delineation of the inter- inositol 3-kinase (Pfeffer et al., 1997). Understanding the
intersections and crosstalk in these signal pathways isactions of STATs and other transcription factors.
essential. Conversely, it is also pertinent that STATs
may have direct effects on inhibiting proliferation byConclusions and Future Directions
The discovery of the Jak/STAT pathway goes a long induction of cyclin-dependent kinase inhibitors, such as
p21 WAF1/CIP1 (Chin et al., 1996). This may explain theway toward explaining cytokine signaling. The require-
ment for Jaks in cytokine signaling is very clear, as antiproliferative effects of the interferons.
Finally, utilizing model organisms like C. elegans, Dro-highlighted by the severe immunodeficiency in humans
and mice with Jak3 mutations. Despite their importance sophila, Dictyostelium, and zebrafish to analyze the
components involved in growth and development willfor transducing cytokine receptor signals, the Jaks do
not seem to contribute to the specificity of cytokine undoubtedly promote advances in understanding mam-
signaling. But STATs do. There are two levels by which malian cellular differentiation.
specificity of cytokine signaling is achieved: (1) STAT So, an appropriate response to thecries from the back
binding to tyrosine- phosphorylated sites on specific seat is ªWe are not there yet, but keep your eyes open
cytokine receptors via STAT SH2 domains and (2) STAT or you'll miss something exciting.º
binding to specific DNA elements.
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